|
| | Issue Date | Title | Author(s) |
| 21 | 2019 | Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity | Elsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid |
| 22 | 2019 | Selective Small Molecule Myeloid Cell Leukemia-1 (MCL-1) Inhibitors: Novel Agents in Cancer Therapy | Ibrahim, Hoda Sobhy; Lasheen, Deena S; Serya, Rabah ; Abu-ELElla, Dalal Abd-ELRahman |
| 23 | Dec-2018 | Identification of new pyrrolo[2,3-d]pyrimidines as potent VEGFR-2 tyrosine kinase inhibitors: Design, synthesis, biological evaluation and molecular modeling | Adel, Mai; Serya, Rabah ; Lasheen, Deena S. ; Khaled A M Abouzid |
| 24 | 15-Jul-2018 | Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors | Milik, Sandra N; Serya, Rabah ; Minucci, Saverio; Lasheen, Deena S. ; Khaled A M Abouzid ; Abdel-Aziz, Amal Kamal |
| 25 | 25-May-2018 | Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens | ElAwamy, Moustafa; Mohammad, Haroon; Hussien, Abdelrahman; Abutaleb, Nader S; Hagras, Mohamed; Serya, Rabah ; Taher, Azza T; Seleem, Mohamed N; Mayhoub, Abdelrahman S; Khaled A M Abouzid |
| 26 | 15-Dec-2017 | How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors | Milik, Sandra N; Lasheen, Deena S; Serya, Rabah ; Abouzid, Khaled A M; Khaled A M Abouzid |
| 27 | 1-Dec-2017 | Novel quinoline-3-carboxamides (Part 2): Design, optimization and synthesis of quinoline based scaffold as EGFR inhibitors with potent anticancer activity | Aly, Rasha M.; Serya, Rabah ; El-Motwally, Amira M.; Abbas, Safinaz; Abou El Ella, Dalal ; Esmat, Ahmed |
| 28 | 30-Jan-2017 | Click and Release: SO2 Prodrugs with Tunable Release Rates | Serya, Rabah ; Khaled A.M.abouzid; Deena S.Lasheen; Xingyue Ji; Binghe Wang; Khaled A M Abouzid |
| 29 | 2017 | An overview on the prospective CDKs inhibitors as anti-cancer drugs | Oudah, Khulood H; Serya, R; Abouzid, K; Serya, Rabah ; Nermin Samir |
| 30 | 2016 | Design and synthesis of some new tri-substituted pyrazole derivatives as anticancer agents | Fahmy, Hoda H; Srour, Aladdin M; Khater, Mai A; El-Manawaty, May A; Serya, Rabah ; Ismail, Mohamed A |
| 31 | 2016 | Design and Synthesis of quinazoline derivatives: Biological evaluation for their Anticancer and VEGFR inhibitory activities | Metwally, Wegdan M; Hegazy, G; Serya, Rabah ; Eid, S; Abou El Ella, DA |
| 32 | 2016 | Quinoline-based small molecules as effective protein kinases inhibitors | Aly, Rasha M; Al-Ansary, Ghada H; Abou El Ella, Dalal A; Serya, Rabah ; Amira, M |
| 33 | Nov-2015 | Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators | Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K; Serya, Rabah ; Ismail, Nasser S M; Chen, Ching-Shih; Dokla, Eman ; Khaled A M Abouzid |
| 34 | 2015 | Design, synthesis and biological evaluation of novel quinazoline-based anti-inflammatory agents acting as PDE4B inhibitors | Serya, Rabah ; Abbas, Abeer Hussin; Ismail, Nasser Saad Mohamed; Esmat, Ahmed; Abou El Ella, Dalal |
| 35 | 2015 | Synthesis and in vitro antiproliferative activity of novel pyrazolo[3,4-d]pyrimidine derivatives | Abdou, Nermin S.; Serya, Rabah ; Esmat, Ahmed ; Tolba, Mai F.; Ismail, Nasser S. M.; Khaled A M Abouzid ; Nermin Samir |
| 16 | Dec-2014 | Design, synthesis, 3D pharmacophore, QSAR, and docking studies of carboxylic acid derivatives as Histone Deacetylase inhibitors and cytotoxic agents | Abdel-Atty, Mona M; Farag, Nahla A; Kassab, Shaymaa E; Serya, Rabah ; Khaled A M Abouzid |
| 17 | Jun-2014 | Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockers | Hussein, Mohammed M; Serya, Rabah ; Abdel Naby, Rana M; Al-Abd, Ahmed M; Saleh, Dalia O; El-Eraky, Wafaa I; Khaled A M Abouzid ; Abou El Ella, Dalal |
| 18 | Apr-2014 | Discovery of new HER2/EGFR dual kinase inhibitors based on the anilinoquinazoline scaffold as potential anti-cancer agents | Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Ahmed, Marawan; Wang, Feng; Khaled A M Abouzid |
| 19 | Mar-2013 | Assessment of new anti-HER2 ligands using combined docking, QM/MM scoring and MD simulation | Ahmed, Marawan; Sadek, Maiada M; Serya, Rabah ; Kafafy, Abdel-Hamid N; Wang, Feng; Khaled A M Abouzid |
| 20 | Mar-2013 | Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors | Elsayed, Mohamed S A; El-Araby, Moustafa E; Serya, Rabah ; El-Khatib, Ahmed H; Linscheid, Michael W; Khaled A M Abouzid |
Loading...